38112003: un (valeur de l'attribut)

SNOMED CT Concept\valeur de l'attribut\nombre\un

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	est un(e) (attribut)	modificateur adjectival général	false	Inferred relationship	Some
un	est un(e) (attribut)	nombre	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely pirfenidone 267 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely stiripentol 500 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely stiripentol 500 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing only pirfenidone in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely stiripentol 250 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely stiripentol 250 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Lenalidomide 20 mg oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Lenalidomide 20 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Lenalidomide 2.5 mg oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Lenalidomide 2.5 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely lenalidomide 25 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely lenalidomide 25 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Lenalidomide 15 mg oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Lenalidomide 15 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely erdosteine 300 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely erdosteine 300 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing only erdosteine in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely lenvatinib (as lenvatinib mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely lenvatinib (as lenvatinib mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely lenvatinib (as lenvatinib mesilate) 4 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely lenvatinib (as lenvatinib mesilate) 4 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 150 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 150 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 75 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 75 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing only bromhexine (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Bromhexine only product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 110 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 110 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing only meloxicam in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
vaccin contenant seulement antigène du méningocoque du sérogroupe B (produit médicinal)	Count of base of active ingredient	False	un	Inferred relationship	Some
Men meningococcal unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only amisulpride in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only live attenuated Yellow fever virus antigen (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Rimegepant only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only rimegepant in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only inactivated whole Rabies lyssavirus antigen	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in cellular line (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in brain tissue (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only live attenuated Rotavirus antigen (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only isatuximab (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Isatuximab only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Anth anthrax unspecfied	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only Human papillomavirus 16 and 18 antigens (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Human papillomavirus 6, 11, 16 and 18 antigens only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only live attenuated Junin virus antigen (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Chol cholera unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Inf influenza unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
HPV human papillomavirus unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Typh typhoid unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Pneu pneumococcal unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Vibrio cholerae antigen only vaccine product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Lasmiditan 50 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Lasmiditan 50 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Inactivated whole Vibrio cholerae antigen only vaccine product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Live attenuated Vibrio cholerae antigen only vaccine product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only inactivated whole Hepatitis A virus antigen (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Typh-O typhoid live oral unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Typh-I typhoid polysaccharide injectable unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only Clostridium tetani toxoid antigen (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
OPV poliomyelitis live unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Bacillus Calmette-Guerin antigen only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Haemophilus influenzae type b capsular polysaccharide antigen conjugated only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
BCG Bacillus Calmette Guerin unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only osilodrostat (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Osilodrostat only product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely osilodrostat (as osilodrostat phosphate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely osilodrostat (as osilodrostat phosphate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely osilodrostat (as osilodrostat phosphate) 1 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value (attribute)	False	un	Inferred relationship	Some	1
Product containing precisely osilodrostat (as osilodrostat phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely osilodrostat (as osilodrostat phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Osilodrostat (as osilodrostat phosphate) 10 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Osilodrostat (as osilodrostat phosphate) 10 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria lineage antigens only vaccine product	Count of base of active ingredient	False	un	Inferred relationship	Some
Pneu-C pneumococcal conjugate unspecified	Count of base of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Ibrutinib 140 mg oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Ibrutinib 140 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely nitisinone 20 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely nitisinone 20 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Minoxidil 50 mg/mL cutaneous solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Minoxidil 50 mg/mL cutaneous solution	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely midostaurin 25 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely midostaurin 25 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely palbociclib 100 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely palbociclib 100 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Palbociclib 75 mg oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Palbociclib 75 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely palbociclib 125 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely palbociclib 125 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely panobinostat (as panobinostat lactate) 15 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely panobinostat (as panobinostat lactate) 15 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Panobinostat (as panobinostat lactate) 10 mg oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Panobinostat (as panobinostat lactate) 10 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely nintedanib (as nintedanib esilate) 150 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely nintedanib (as nintedanib esilate) 150 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Eliglustat (as eliglustat tartrate) 84 mg oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Eliglustat (as eliglustat tartrate) 84 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ixazomib (as ixazomib citrate) 4 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ixazomib (as ixazomib citrate) 4 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1

Start Previous Page 107 of 217 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
615211000077111	un (valeur de l'attribut)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
771016011	One (qualifier value)	en	Fully specified name	Inactive	Only initial character case insensitive (core metadata concept)	SNOMED CT core